Zhenzhu Pharma is dedicated to improving human health through scientific innovation and high-quality pharmaceutical products.
Learn MoreWe are a global pharmaceutical company focused on innovative drug development, dedicated to improving human health through science.
Strict adherence to international GMP standards ensures every product meets the highest quality requirements for patient safety.
Significant investment in drug research with multiple projects in development, focusing on unmet medical needs.
Operations across multiple countries and regions, collaborating with local healthcare providers to serve patients worldwide.
Our research pipeline covers multiple therapeutic areas, dedicated to providing innovative treatment solutions.
Focused on developing treatments for hypertension, coronary heart disease, and other cardiovascular conditions.
Developing innovative targeted therapies for various types of cancer.
Researching novel immunomodulators for treating autoimmune diseases.
Focused on treatments for neurodegenerative diseases and mental health disorders.
Our R&D center is equipped with world-class facilities and professional teams, dedicated to advancing pharmaceutical science.
Stay updated with Zhenzhu Pharma's latest developments and industry insights.
Our self-developed targeted therapy ZZP-001 has received regulatory approval to enter Phase III clinical trials, offering new hope for cancer patients.
Zhenzhu Pharma signs strategic agreement with a leading European pharmaceutical company to jointly develop and market cardiovascular treatments.
At the 2024 Global Pharmaceutical Innovation Summit, Zhenzhu Pharma was honored with the "Innovative Pharmaceutical Company of the Year" award.
Get the latest company updates and industry news delivered to your inbox.